158 related articles for article (PubMed ID: 26012464)
21. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
22. Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
Stöllberger C; Finsterer J
J Neurol; 2012 Jan; 259(1):168-9. PubMed ID: 22124666
[No Abstract] [Full Text] [Related]
23. New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Tripodi A; Palareti G
J Intern Med; 2012 Jun; 271(6):554-65. PubMed ID: 22443239
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
[TBL] [Abstract][Full Text] [Related]
25. Indirect comparison studies--are they useful? Insights from the novel oral anticoagulants for stroke prevention in atrial fibrillation.
Skjøth F; Larsen TB; Rasmussen LH
Thromb Haemost; 2012 Sep; 108(3):405-6. PubMed ID: 22782445
[No Abstract] [Full Text] [Related]
26. Treatment of atrial fibrillation.
Med Lett Drugs Ther; 2014 Jul; 56(1446):53-8. PubMed ID: 25046325
[No Abstract] [Full Text] [Related]
27. {blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF.
Drug Ther Bull; 2014 Jan; 52(1):6-9. PubMed ID: 24401533
[TBL] [Abstract][Full Text] [Related]
28. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
29. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
30. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
Douketis J; Bell AD; Eikelboom J; Liew A
Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
[TBL] [Abstract][Full Text] [Related]
31. Response.
Douketis J; Eikelboom J; Liew A; Bell AD
Can Fam Physician; 2015 Jan; 61(1):24-5. PubMed ID: 25609517
[No Abstract] [Full Text] [Related]
32. Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.
Douketis J; Bell AD; Eikelboom J; Liew A
Can Fam Physician; 2014 Nov; 60(11):997-1001. PubMed ID: 25392439
[TBL] [Abstract][Full Text] [Related]
33. Outpatient management of oral anticoagulation in atrial fibrillation.
Manning JA
Crit Care Nurs Clin North Am; 2013 Dec; 25(4):481-7, vi. PubMed ID: 24267284
[TBL] [Abstract][Full Text] [Related]
34. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
35. [The role of internal medicine in preventing stroke in atrial fibrillation].
Hernández M; Suárez C
Med Clin (Barc); 2012 Oct; 139 Suppl 2():36-40. PubMed ID: 23498071
[TBL] [Abstract][Full Text] [Related]
36. New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management. Australasian Society of Thrombosis and Haemostasis.
Tran H; Joseph J; Young L; McRae S; Curnow J; Nandurkar H; Wood P; McLintock C
Intern Med J; 2014 Jun; 44(6):525-36. PubMed ID: 24946813
[TBL] [Abstract][Full Text] [Related]
37. Well-managed warfarin is superior to NOACs.
Trusler M
Can Fam Physician; 2015 Jan; 61(1):23-4. PubMed ID: 25609516
[No Abstract] [Full Text] [Related]
38. New antithrombotic drugs and European approval processes.
Marijon E; Fauchier L; Le Heuzey JY
Lancet; 2011 Aug; 378(9792):662-3. PubMed ID: 21856473
[No Abstract] [Full Text] [Related]
39. Head-to-head or indirect comparisons of the novel oral anticoagulants in atrial fibrillation: what's next?
Harenberg J; Marx S; Wehling M
Thromb Haemost; 2012 Sep; 108(3):407-9. PubMed ID: 22837027
[No Abstract] [Full Text] [Related]
40. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]